InvestorsHub Logo
Followers 19
Posts 4615
Boards Moderated 0
Alias Born 04/12/2017

Re: Investor2014 post# 403026

Monday, 02/13/2023 7:09:45 AM

Monday, February 13, 2023 7:09:45 AM

Post# of 466667
Curious, so you are saying AVXL is flat out LYING TO US when they say this, yes or no will do:

The trial met both its co-primary and key secondary endpoints, showing statistically significant and clinically meaningful improvement in cognition and function as measured by ADAS-Cog, ADCS-ADL, and CDR-SB, respectively.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News